[PDF][PDF] 中国乳腺癌患者BRCA1/2 基因检测与临床应用专家共识(2018 年版)
C PTEN - 中国癌症杂志, 2018 - china-oncology.com
中国乳腺癌患者BRCA1/2基因检测与临床应用专家共识(2018年版) Page 1 《中国癌症杂志》2018年
第28卷第10期 CHINA ONCOLOGY 2018 Vol.28 No.10 787 欢迎关注本刊公众号 ·指南与共识 …
第28卷第10期 CHINA ONCOLOGY 2018 Vol.28 No.10 787 欢迎关注本刊公众号 ·指南与共识 …
BRCA 1/2 mutations by next-generation sequencing testing in 200 Romanian high-risk patients with breast cancer.
AE Eniu, NZ Antone, A Stoian, E Dronca, RD Matei… - 2017 - ascopubs.org
e13116 Background: To determine types and frequencies of BRCA 1 (B1) or BRCA2 (B2)
mutations in high-risk Romanian breast cancer patients, as there is no data published in this …
mutations in high-risk Romanian breast cancer patients, as there is no data published in this …
The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer
L Chen, F Fu, M Huang, J Lv, W Zhang… - Breast Cancer Research …, 2020 - Springer
Purpose BRCA1/2 mutations represent a high risk of breast cancer and are related to early-
onset breast cancer. However, few studies have reported the relationship between BRCA1/2 …
onset breast cancer. However, few studies have reported the relationship between BRCA1/2 …
Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing
Abstract Purpose BRCA1 and BRCA2 (BRCA1/2) are two major high-penetrance breast
cancer predisposition genes, mutations in which can lead to high risks and early onset of …
cancer predisposition genes, mutations in which can lead to high risks and early onset of …
Chinese expert consensus on BRCA1/2 variant interpretation (2021 version)
CPQC Center - Zhonghua bing li xue za zhi= Chinese …, 2021 - pubmed.ncbi.nlm.nih.gov
乳腺癌易感基因 (breast cancer susceptibility gene, BRCA) 包括 BRCA1 和 BRCA2,
是重要的抑癌基因, 其编码产物参与 DNA 损伤同源性重组修复. BRCA1/2 基因检测在卵巢癌 …
是重要的抑癌基因, 其编码产物参与 DNA 损伤同源性重组修复. BRCA1/2 基因检测在卵巢癌 …
Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
F Xie, S Wang - Chinese Medical Journal, 2021 - mednexus.org
Discussion Indications for BRCA1/2 testing were recommended by considering national
conditions and referring to relevant guidelines and expert consensus.[6, 8, 9, 10, 11, 12] …
conditions and referring to relevant guidelines and expert consensus.[6, 8, 9, 10, 11, 12] …
The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: screening of 2,991 patients and 1,043 controls by next-generation …
LGT Lang GuanTian, SJX Shi JinXiu, HX Hu Xin… - 2017 - cabidigitallibrary.org
To characterize the prevalence of BRCA mutations and characteristics of BRCA carriers in
China and to update the clinical recommendations for BRCA testing, we conducted a wide …
China and to update the clinical recommendations for BRCA testing, we conducted a wide …
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
Breast cancer patients with BRCA1/2‐driven tumors may benefit from targeted therapy. It is
not clear whether current BRCA screening guidelines are effective at identifying these …
not clear whether current BRCA screening guidelines are effective at identifying these …
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
LJM Li JingMei, WWX Wen WeiXiong, M Eklund… - 2019 - cabidigitallibrary.org
Breast cancer patients with BRCA1/2-driven tumors may benefit from targeted therapy. It is
not clear whether current BRCA screening guidelines are effective at identifying these …
not clear whether current BRCA screening guidelines are effective at identifying these …
The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation …
GT Lang, JX Shi, X Hu, CH Zhang… - … journal of cancer, 2017 - Wiley Online Library
To characterize the prevalence of BRCA mutations and characteristics of BRCA carriers in
China and to update the clinical recommendations for BRCA testing, we conducted a wide …
China and to update the clinical recommendations for BRCA testing, we conducted a wide …